Insider Trading Activity G1 Therapeutics (NASDAQ:GTHX) – Insider Sold 7,500 shares of Stock

ME Staff
-
0

Insider Trading Activity For G1 Therapeutics (NASDAQ:GTHX)

Mark A Velleca , Insider of G1 Therapeutics (NASDAQ:GTHX) reportedly Sold 7,500 shares of the company’s stock at an average price of 36 for a total transaction amount of $270,000.00 SEC Form

Insider Trading History For G1 Therapeutics (NASDAQ:GTHX)

  • On 5/22/2017 Ra Capital Healthcare Fund Lp, Insider, bought 400,000 with an average share price of $15.00 per share and the total transaction amounting to $6,000,000.00.
  • On 5/22/2017 Fredric N Eshelman, Director, bought 300,000 with an average share price of $15.00 per share and the total transaction amounting to $4,500,000.00.
  • On 5/22/2017 Clay Thorp, Major Shareholder, bought 133,333 with an average share price of $15.00 per share and the total transaction amounting to $1,999,995.00.
  • On 11/13/2017 Fredric N Eshelman, Director, bought 250,000 with an average share price of $19.73 per share and the total transaction amounting to $4,932,500.00.
  • On 11/20/2017 Medimmune Ventures, Inc., Major Shareholder, sold 200,000 with an average share price of $20.01 per share and the total transaction amounting to $4,002,000.00.
  • On 12/1/2017 Medimmune Ventures, Inc., Major Shareholder, sold 133,906 with an average share price of $19.75 per share and the total transaction amounting to $2,644,643.50.
  • On 12/15/2017 Medimmune Ventures, Inc., Major Shareholder, sold 200,000 with an average share price of $19.75 per share and the total transaction amounting to $3,950,000.00.

    • Analyst Ratings History For G1 Therapeutics (NASDAQ:GTHX)

    • On 6/12/2017 Wedbush Initiated Coverage of rating Outperform with a price target of $31.00
    • On 3/5/2018 Cowen Reiterated Rating Buy
    • On 3/6/2018 JPMorgan Chase Reiterated Rating Overweight to Overweight with a price target of $33.00 to $39.00
    • On 3/7/2018 BTIG Research Reiterated Rating Buy with a price target of $48.00
    • On 3/13/2018 Needham & Company LLC Boost Price Target of rating Buy with a price target of $42.00

    Recent Trading Activity for G1 Therapeutics (NASDAQ:GTHX)
    Shares of G1 Therapeutics closed the previous trading session at 40.97 up +4.68 12.89% with 41.41999816894531 shares trading hands.